Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Dec 3;9:78.
doi: 10.1186/1471-244X-9-78.

A New Clinical Rating Scale for Work Absence and Productivity: Validation in Patients With Major Depressive Disorder

Free PMC article
Comparative Study

A New Clinical Rating Scale for Work Absence and Productivity: Validation in Patients With Major Depressive Disorder

Raymond W Lam et al. BMC Psychiatry. .
Free PMC article


Background: The prevalence of major depressive disorder (MDD) is highest in working age people and depression causes significant impairment in occupational functioning. Work productivity and work absence should be incorporated into clinical assessments but currently available scales may not be optimized for clinical use. This study seeks to validate the Lam Employment Absence and Productivity Scale (LEAPS), a 10-item self-report questionnaire that takes 3-5 minutes to complete.

Methods: The study sample consisted of consecutive patients attending a Mood Disorders outpatient clinic who were in full- or part-time paid work. All patients met DSM-IV criteria for MDD and completed during their intake assessment the LEAPS, the self-rated version of the Quick Inventory for Depressive Symptomatology (QIDS-SR), the Sheehan Disability Scale (SDS) and the Health and Work Performance Questionnaire (HPQ). Standard psychometric analyses for validation were conducted.

Results: A total of 234 patients with MDD completed the assessments. The LEAPS displayed excellent internal consistency as assessed by Cronbach's alpha of 0.89. External validity was assessed by comparing the LEAPS to the other clinical and work functioning scales. The LEAPS total score was significantly correlated with the SDS work disability score (r = 0.63, p < 0.01) and the Global Work Performance rating from the HPQ (r = -0.79, p < 0.01). The LEAPS total score also increased with greater depression severity.

Conclusion: The LEAPS displays good internal and external validity in a population of patients with MDD attending an outpatient clinic, which suggests that it may be a clinically useful tool to assess and monitor work functioning and productivity in depressed patients.


Figure 1
Figure 1
Significant impairment in work productivity items (from the LEAPS) versus depression severity (based on QIDS-SR score).

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles


    1. Stephens T, Joubert N. The economic burden of mental health problems in Canada. Chronic Dis Can. 2001;22:18–23. - PubMed
    1. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465–1475. - PubMed
    1. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87–98. - PubMed
    1. Patten SB, Wang JL, Williams JV, Currie S, Beck CA, Maxwell CJ, el Guebaly N. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51:84–90. - PubMed
    1. Kessler RC, Barber C, Birnbaum HG, Frank RG, Greenberg PE, Rose RM, Simon GE, Wang P. Depression in the workplace: effects on short-term disability. Health Aff (Millwood) 1999;18:163–171. doi: 10.1377/hlthaff.18.5.163. - DOI - PubMed

Publication types

MeSH terms